Skip to main content

Peer Review reports

From: Cancer-associated mutations reveal a novel role for EpCAM as an inhibitor of cathepsin-L and tumor cell invasion

Original Submission
3 Nov 2020 Submitted Original manuscript
28 Dec 2020 Reviewed Reviewer Report
11 Jan 2021 Reviewed Reviewer Report
3 Mar 2021 Author responded Author comments - Narendra Sankpal
Resubmission - Version 2
3 Mar 2021 Submitted Manuscript version 2
21 Mar 2021 Reviewed Reviewer Report
23 Mar 2021 Reviewed Reviewer Report
7 Apr 2021 Author responded Author comments - Narendra Sankpal
Resubmission - Version 3
7 Apr 2021 Submitted Manuscript version 3
21 Apr 2021 Author responded Author comments - Narendra Sankpal
Resubmission - Version 4
21 Apr 2021 Submitted Manuscript version 4
Publishing
22 Apr 2021 Editorially accepted
12 May 2021 Article published 10.1186/s12885-021-08239-z

You can find further information about peer review here.

Back to article page